Global Antispasmodics Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: GFB16B66C826EN
QYResearch

Abstracts

Antispasmodics Drugs market is segmented by Route of Administration, and by Application. Players, stakeholders, and other participants in the global Antispasmodics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Route of Administration and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study

• Allergan
• Hikma Pharmaceuticals
• Lannett
• Mylan
• Nexus Pharmaceuticals
• Akorn
• Aurobindo Pharma
• Daiichi Sankyo
• Fresenius Kabi
• Shanghai Fosun Pharmaceutical
• SunGen Pharma

Market segment by Route of Administration, the product can be split into

• Oral
• Injectable
• Others

Market segment by Application, split into

• Hospital
• Special Clinic
• Home Care
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antispasmodics Drugs Revenue
1.4 Market by Route of Administration
  1.4.1 Global Antispasmodics Drugs Market Size Growth Rate by Route of Administration: 2020 VS 2026
  1.4.2 Oral
  1.4.3 Injectable
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Antispasmodics Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Special Clinic
  1.5.4 Home Care
  1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Antispasmodics Drugs Market Perspective (2015-2026)
2.2 Global Antispasmodics Drugs Growth Trends by Regions
  2.2.1 Antispasmodics Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Antispasmodics Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Antispasmodics Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Antispasmodics Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Antispasmodics Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Antispasmodics Drugs Players by Market Size
  3.1.1 Global Top Antispasmodics Drugs Players by Revenue (2015-2020)
  3.1.2 Global Antispasmodics Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Antispasmodics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antispasmodics Drugs Market Concentration Ratio
  3.2.1 Global Antispasmodics Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Antispasmodics Drugs Revenue in 2019
3.3 Antispasmodics Drugs Key Players Head office and Area Served
3.4 Key Players Antispasmodics Drugs Product Solution and Service
3.5 Date of Enter into Antispasmodics Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY ROUTE OF ADMINISTRATION (2015-2026)

4.1 Global Antispasmodics Drugs Historic Market Size by Route of Administration (2015-2020)
4.2 Global Antispasmodics Drugs Forecasted Market Size by Route of Administration (2021-2026)

5 MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Antispasmodics Drugs Market Size by Application (2015-2020)
5.2 Global Antispasmodics Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Antispasmodics Drugs Market Size (2015-2020)
6.2 Antispasmodics Drugs Key Players in North America (2019-2020)
6.3 North America Antispasmodics Drugs Market Size by Route of Administration (2015-2020)
6.4 North America Antispasmodics Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Antispasmodics Drugs Market Size (2015-2020)
7.2 Antispasmodics Drugs Key Players in Europe (2019-2020)
7.3 Europe Antispasmodics Drugs Market Size by Route of Administration (2015-2020)
7.4 Europe Antispasmodics Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Antispasmodics Drugs Market Size (2015-2020)
8.2 Antispasmodics Drugs Key Players in China (2019-2020)
8.3 China Antispasmodics Drugs Market Size by Route of Administration (2015-2020)
8.4 China Antispasmodics Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Antispasmodics Drugs Market Size (2015-2020)
9.2 Antispasmodics Drugs Key Players in Japan (2019-2020)
9.3 Japan Antispasmodics Drugs Market Size by Route of Administration (2015-2020)
9.4 Japan Antispasmodics Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Antispasmodics Drugs Market Size (2015-2020)
10.2 Antispasmodics Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antispasmodics Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Antispasmodics Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Antispasmodics Drugs Market Size (2015-2020)
11.2 Antispasmodics Drugs Key Players in India (2019-2020)
11.3 India Antispasmodics Drugs Market Size by Type (2015-2020)
11.4 India Antispasmodics Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Antispasmodics Drugs Market Size (2015-2020)
12.2 Antispasmodics Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Antispasmodics Drugs Market Size by Type (2015-2020)
12.4 Central & South America Antispasmodics Drugs Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Allergan
  13.1.1 Allergan Company Details
  13.1.2 Allergan Business Overview
  13.1.3 Allergan Antispasmodics Drugs Introduction
  13.1.4 Allergan Revenue in Antispasmodics Drugs Business (2015-2020))
  13.1.5 Allergan Recent Development
13.2 Hikma Pharmaceuticals
  13.2.1 Hikma Pharmaceuticals Company Details
  13.2.2 Hikma Pharmaceuticals Business Overview
  13.2.3 Hikma Pharmaceuticals Antispasmodics Drugs Introduction
  13.2.4 Hikma Pharmaceuticals Revenue in Antispasmodics Drugs Business (2015-2020)
  13.2.5 Hikma Pharmaceuticals Recent Development
13.3 Lannett
  13.3.1 Lannett Company Details
  13.3.2 Lannett Business Overview
  13.3.3 Lannett Antispasmodics Drugs Introduction
  13.3.4 Lannett Revenue in Antispasmodics Drugs Business (2015-2020)
  13.3.5 Lannett Recent Development
13.4 Mylan
  13.4.1 Mylan Company Details
  13.4.2 Mylan Business Overview
  13.4.3 Mylan Antispasmodics Drugs Introduction
  13.4.4 Mylan Revenue in Antispasmodics Drugs Business (2015-2020)
  13.4.5 Mylan Recent Development
13.5 Nexus Pharmaceuticals
  13.5.1 Nexus Pharmaceuticals Company Details
  13.5.2 Nexus Pharmaceuticals Business Overview
  13.5.3 Nexus Pharmaceuticals Antispasmodics Drugs Introduction
  13.5.4 Nexus Pharmaceuticals Revenue in Antispasmodics Drugs Business (2015-2020)
  13.5.5 Nexus Pharmaceuticals Recent Development
13.6 Akorn
  13.6.1 Akorn Company Details
  13.6.2 Akorn Business Overview
  13.6.3 Akorn Antispasmodics Drugs Introduction
  13.6.4 Akorn Revenue in Antispasmodics Drugs Business (2015-2020)
  13.6.5 Akorn Recent Development
13.7 Aurobindo Pharma
  13.7.1 Aurobindo Pharma Company Details
  13.7.2 Aurobindo Pharma Business Overview
  13.7.3 Aurobindo Pharma Antispasmodics Drugs Introduction
  13.7.4 Aurobindo Pharma Revenue in Antispasmodics Drugs Business (2015-2020)
  13.7.5 Aurobindo Pharma Recent Development
13.8 Daiichi Sankyo
  13.8.1 Daiichi Sankyo Company Details
  13.8.2 Daiichi Sankyo Business Overview
  13.8.3 Daiichi Sankyo Antispasmodics Drugs Introduction
  13.8.4 Daiichi Sankyo Revenue in Antispasmodics Drugs Business (2015-2020)
  13.8.5 Daiichi Sankyo Recent Development
13.9 Fresenius Kabi
  13.9.1 Fresenius Kabi Company Details
  13.9.2 Fresenius Kabi Business Overview
  13.9.3 Fresenius Kabi Antispasmodics Drugs Introduction
  13.9.4 Fresenius Kabi Revenue in Antispasmodics Drugs Business (2015-2020)
  13.9.5 Fresenius Kabi Recent Development
13.10 Shanghai Fosun Pharmaceutical
  13.10.1 Shanghai Fosun Pharmaceutical Company Details
  13.10.2 Shanghai Fosun Pharmaceutical Business Overview
  13.10.3 Shanghai Fosun Pharmaceutical Antispasmodics Drugs Introduction
  13.10.4 Shanghai Fosun Pharmaceutical Revenue in Antispasmodics Drugs Business (2015-2020)
  13.10.5 Shanghai Fosun Pharmaceutical Recent Development
13.11 SunGen Pharma
  10.11.1 SunGen Pharma Company Details
  10.11.2 SunGen Pharma Business Overview
  10.11.3 SunGen Pharma Antispasmodics Drugs Introduction
  10.11.4 SunGen Pharma Revenue in Antispasmodics Drugs Business (2015-2020)
  10.11.5 SunGen Pharma Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Antispasmodics Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Antispasmodics Drugs Revenue
Table 3. Ranking of Global Top Antispasmodics Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antispasmodics Drugs Market Size Growth Rate by Route of Administration (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Injectable
Table 7. Key Players of Others
Table 8. Global Antispasmodics Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Antispasmodics Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Antispasmodics Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Antispasmodics Drugs Market Share by Regions (2015-2020)
Table 12. Global Antispasmodics Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Antispasmodics Drugs Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Antispasmodics Drugs Market Growth Strategy
Table 18. Main Points Interviewed from Key Antispasmodics Drugs Players
Table 19. Global Antispasmodics Drugs Revenue by Players (2015-2020) (Million US$)
Table 20. Global Antispasmodics Drugs Market Share by Players (2015-2020)
Table 21. Global Top Antispasmodics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antispasmodics Drugs as of 2019)
Table 22. Global Antispasmodics Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Antispasmodics Drugs Product Solution and Service
Table 25. Date of Enter into Antispasmodics Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antispasmodics Drugs Market Size by Route of Administration (2015-2020) (Million US$)
Table 28. Global Antispasmodics Drugs Market Size Share by Route of Administration (2015-2020)
Table 29. Global Antispasmodics Drugs Revenue Market Share by Route of Administration (2021-2026)
Table 30. Global Antispasmodics Drugs Market Size Share by Application (2015-2020)
Table 31. Global Antispasmodics Drugs Market Size by Application (2015-2020) (Million US$)
Table 32. Global Antispasmodics Drugs Market Size Share by Application (2021-2026)
Table 33. North America Key Players Antispasmodics Drugs Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Antispasmodics Drugs Market Share (2019-2020)
Table 35. North America Antispasmodics Drugs Market Size by Route of Administration (2015-2020) (Million US$)
Table 36. North America Antispasmodics Drugs Market Share by Route of Administration (2015-2020)
Table 37. North America Antispasmodics Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. North America Antispasmodics Drugs Market Share by Application (2015-2020)
Table 39. Europe Key Players Antispasmodics Drugs Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Antispasmodics Drugs Market Share (2019-2020)
Table 41. Europe Antispasmodics Drugs Market Size by Route of Administration (2015-2020) (Million US$)
Table 42. Europe Antispasmodics Drugs Market Share by Route of Administration (2015-2020)
Table 43. Europe Antispasmodics Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Antispasmodics Drugs Market Share by Application (2015-2020)
Table 45. China Key Players Antispasmodics Drugs Revenue (2019-2020) (Million US$)
Table 46. China Key Players Antispasmodics Drugs Market Share (2019-2020)
Table 47. China Antispasmodics Drugs Market Size by Route of Administration (2015-2020) (Million US$)
Table 48. China Antispasmodics Drugs Market Share by Route of Administration (2015-2020)
Table 49. China Antispasmodics Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. China Antispasmodics Drugs Market Share by Application (2015-2020)
Table 51. Japan Key Players Antispasmodics Drugs Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Antispasmodics Drugs Market Share (2019-2020)
Table 53. Japan Antispasmodics Drugs Market Size by Route of Administration (2015-2020) (Million US$)
Table 54. Japan Antispasmodics Drugs Market Share by Route of Administration (2015-2020)
Table 55. Japan Antispasmodics Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Antispasmodics Drugs Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Antispasmodics Drugs Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Antispasmodics Drugs Market Share (2019-2020)
Table 59. Southeast Asia Antispasmodics Drugs Market Size by Route of Administration (2015-2020) (Million US$)
Table 60. Southeast Asia Antispasmodics Drugs Market Share by Route of Administration (2015-2020)
Table 61. Southeast Asia Antispasmodics Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Antispasmodics Drugs Market Share by Application (2015-2020)
Table 63. India Key Players Antispasmodics Drugs Revenue (2019-2020) (Million US$)
Table 64. India Key Players Antispasmodics Drugs Market Share (2019-2020)
Table 65. India Antispasmodics Drugs Market Size by Route of Administration (2015-2020) (Million US$)
Table 66. India Antispasmodics Drugs Market Share by Route of Administration (2015-2020)
Table 67. India Antispasmodics Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. India Antispasmodics Drugs Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Antispasmodics Drugs Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Antispasmodics Drugs Market Share (2019-2020)
Table 71. Central & South America Antispasmodics Drugs Market Size by Route of Administration (2015-2020) (Million US$)
Table 72. Central & South America Antispasmodics Drugs Market Share by Route of Administration (2015-2020)
Table 73. Central & South America Antispasmodics Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Antispasmodics Drugs Market Share by Application (2015-2020)
Table 75. Allergan Company Details
Table 76. Allergan Business Overview
Table 77. Allergan Product
Table 78. Allergan Revenue in Antispasmodics Drugs Business (2015-2020) (Million US$)
Table 79. Allergan Recent Development
Table 80. Hikma Pharmaceuticals Company Details
Table 81. Hikma Pharmaceuticals Business Overview
Table 82. Hikma Pharmaceuticals Product
Table 83. Hikma Pharmaceuticals Revenue in Antispasmodics Drugs Business (2015-2020) (Million US$)
Table 84. Hikma Pharmaceuticals Recent Development
Table 85. Lannett Company Details
Table 86. Lannett Business Overview
Table 87. Lannett Product
Table 88. Lannett Revenue in Antispasmodics Drugs Business (2015-2020) (Million US$)
Table 89. Lannett Recent Development
Table 90. Mylan Company Details
Table 91. Mylan Business Overview
Table 92. Mylan Product
Table 93. Mylan Revenue in Antispasmodics Drugs Business (2015-2020) (Million US$)
Table 94. Mylan Recent Development
Table 95. Nexus Pharmaceuticals Company Details
Table 96. Nexus Pharmaceuticals Business Overview
Table 97. Nexus Pharmaceuticals Product
Table 98. Nexus Pharmaceuticals Revenue in Antispasmodics Drugs Business (2015-2020) (Million US$)
Table 99. Nexus Pharmaceuticals Recent Development
Table 100. Akorn Company Details
Table 101. Akorn Business Overview
Table 102. Akorn Product
Table 103. Akorn Revenue in Antispasmodics Drugs Business (2015-2020) (Million US$)
Table 104. Akorn Recent Development
Table 105. Aurobindo Pharma Company Details
Table 106. Aurobindo Pharma Business Overview
Table 107. Aurobindo Pharma Product
Table 108. Aurobindo Pharma Revenue in Antispasmodics Drugs Business (2015-2020) (Million US$)
Table 109. Aurobindo Pharma Recent Development
Table 110. Daiichi Sankyo Business Overview
Table 111. Daiichi Sankyo Product
Table 112. Daiichi Sankyo Company Details
Table 113. Daiichi Sankyo Revenue in Antispasmodics Drugs Business (2015-2020) (Million US$)
Table 114. Daiichi Sankyo Recent Development
Table 115. Fresenius Kabi Company Details
Table 116. Fresenius Kabi Business Overview
Table 117. Fresenius Kabi Product
Table 118. Fresenius Kabi Revenue in Antispasmodics Drugs Business (2015-2020) (Million US$)
Table 119. Fresenius Kabi Recent Development
Table 120. Shanghai Fosun Pharmaceutical Company Details
Table 121. Shanghai Fosun Pharmaceutical Business Overview
Table 122. Shanghai Fosun Pharmaceutical Product
Table 123. Shanghai Fosun Pharmaceutical Revenue in Antispasmodics Drugs Business (2015-2020) (Million US$)
Table 124. Shanghai Fosun Pharmaceutical Recent Development
Table 125. SunGen Pharma Company Details
Table 126. SunGen Pharma Business Overview
Table 127. SunGen Pharma Product
Table 128. SunGen Pharma Revenue in Antispasmodics Drugs Business (2015-2020) (Million US$)
Table 129. SunGen Pharma Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Antispasmodics Drugs Market Share by Route of Administration: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injectable Features
Figure 4. Others Features
Figure 5. Global Antispasmodics Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Special Clinic Case Studies
Figure 8. Home Care Case Studies
Figure 9. Others Case Studies
Figure 10. Antispasmodics Drugs Report Years Considered
Figure 11. Global Antispasmodics Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Antispasmodics Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Antispasmodics Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Antispasmodics Drugs Market Share by Players in 2019
Figure 16. Global Top Antispasmodics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antispasmodics Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Antispasmodics Drugs Revenue in 2019
Figure 18. North America Antispasmodics Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Antispasmodics Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Antispasmodics Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Antispasmodics Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Antispasmodics Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Antispasmodics Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Antispasmodics Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed